Stock Price
2024-10-29
Market Capitalization
2024-08-26
Revenue
FY, 2023
Phase III Trials Products (Biosimilars)
FY, 2021
Registration Phase Products (Pharmaceuticals)
FY, 2021
Phase I/II Trials Products
FY, 2022
Switzerland
Novartis Forum 1, Fabrikstrasse 6
United States
2555 W Midway Blvd
United States
250 Massachusetts Ave
United States
Five Cambridge Center, Suite 603
United States
1890 Rutherford Rd
United States
2275 Half Day Rd Ste 200